Start Your Research at UAB
Popular Tools & Tasks
-
- Required Documents Tool
- General Information
- Extramural Checklist and Instructions
- Expedited Checklist
- Responsible Personnel List and Instructions
- Rebudgeting Request
- UAB Internal Federal Budget Form
- Industry Budget Template
- 30 Day Notification of Intent to Submit an SBIR/STTR Grant Application with a Small Business Concern (SBC)
- FDP Data Transfer and Use Agreement (DTUA) Templates
- FDP Subaward Forms
Not able to find a form above? Please visit the OSP Forms webpage.
-
- Electronic (Adobe Sign) Extramural Checklist
- Electronic (Adobe Sign) Cost Sharing Commitment
- Electronic (Adobe Sign) In-Kind Cost Sharing
- Electronic (Adobe Sign) Indirect Cost Revenue Redistribution Form
- Electronic (Adobe Sign) Rebudget Request
- Electronic (Adobe Sign) SBIR/STTR Extramural Support Checklist
- Electronic Signatures on OSP Forms
-
- Proposal Due Date Calculator
- Find Your Officer or Specialist
- Find Required Documents
- Fee for Service Decision Tree
- Commonly Used OSP IRAP Statuses
and What They Mean (PDF Version) - Update Contacts/Award Manager (PDF)
- Acronyms and Definitions
- JIT Instructions
- Other Support Template and Instructions
- Award Reports and Visualizations
For more information, please visit the Researcher's Toolkit and Project Management webpages.
-
- Facilities and Administrative (F&A) Costs
- Federally Negotiated and Institutionally Established F&A Rate Table
- Clinical Trial F&A Costs and Rate Flowchart
- Continuing Professional Education F&A Rate
- Composite Fringe Benefit (CFB) Rates
- UAB Colleges and Universities Rate Agreement
- UAB Direct vs Indirect Cost Policy and Grid
- Normally Charged as F&A (Indirect) Costs to be Charged as Direct Costs
- OMB Uniform Guidance (Grants.gov)
-
- Federal Grants
- Federal Contracts
- Industry Projects
- Non-Profit / Foundation Projects
- Annual Progress Reports (RPPR)
- Outgoing Federal Subawards
- Data Use Agreements (DUA)
- VA Interagency Personnel Agreements (IPA)
- VA Memorandum of Understanding (MOU)
- Confidentiality Disclosure Agreements (CDA)
- Continuing Professional Education (CPE)
- Non-Sponsor Funded Research
- Project Master Agreements
-
- Proposal Submission Requirements
- Other Support & Transparency in Research
- UAB Signature Authority
- Definition of a Principal Investigator
- Facilities and Administrative Rate Policy
- Establishing a Subrecipient Agreement
- Number of Submissions Limited by Sponsor
- Policy Concerning the Responsible Conduct of Research and Other Scholarly Activities
- Execution and Review of Contracts for the University of Alabama at Birmingham
- UAB Enterprise Conflict of Interest and Conflict of Commitment Policy
- Policy Concerning the Use of UAB Resources by External Entities
- Effort Reporting Policy
- Effort Reporting Procedures
- UAB Expectations for Research Sponsors
-
Please see our dedicated Frequently Asked Questions webpage.
News & Announcements
Latest News
-
UAB-developed viral immunotherapy for pediatric brain tumors shows promise
G207, an immunotherapy derived from a modified herpes virus is well tolerated in children with gliomas, and shows signs of clinical effectiveness -
Who will benefit from new ‘game-changing’ weight-loss drug semaglutide?
Get the latest on what UAB’s Timothy Garvey,M.D., calls “a very powerful tool to treat obesity.” -
The tuberculosis pathogen releases its toxin by a novel protein transport system
This transport system may be widespread across many Gram-positive bacteria that contain proteins in the WXG100 superfamily. Tuberculosis kills 1 million people each year. -
Race and poverty appear to guide heart muscle DNA methylation in heart-failure patients
Differences in DNA methylation correlated with differences in heart-failure outcomes, as measured by two-year mortality. -
Spatial mapping of COVID-19 and H1N1 influenza show differential transcriptional signatures
Using spatial transcriptomics, UAB researchers set out to understand the differences and similarities between two viral infections causing acute lung injury, as it could improve patient care, as well as identify novel therapeutic targets. -
Obesity is associated with poor outcomes in heart failure, but achieving biomarker-based treatment target goals implies good prognosis
Heart failure is a leading cause of death in the United States. Highly effective medications are now available, and the disease is manageable if patients seek care and take their prescribed medications regularly.
